CBZ 0.00% 5.2¢ cbio limited

Ann: Headline Clinical Trial Results , page-2

  1. 310 Posts.
    lightbulb Created with Sketch. 3
    1st paragraph not the best news but thereafter all good especially the bit about significant results for the long term suffers which contradicts the 1st paragraph,and still no side affects!


 
watchlist Created with Sketch. Add CBZ (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.